ASHG 2018

October 16-20
San Diego Convention Center
Booth 845


Oral Presentation by Dennis Eastburn, PhD, Mission Bio Chief Scientific Officer
Longitudinal monitoring of AML tumors with high-throughput single-cell DNA sequencing reveals rare clones prognostic for disease progression and therapy response.
Friday, October 19, 9:00 – 9:15AM

Ballroom 20BC, Upper Level

Filed under: Uncategorized